Improving Delivery of Poorly Soluble Drugs Using Nanoparticles Wednesday, February 03, 2016 A technology that could forever change the delivery of drugs is undergoing evaluation by the Technology Evaluation Consortium™ (TEC). Developed by researchers at Northeastern University, the technology is capable of creating nanoparticle structures that could deliver drugs into the bloodstream orally – despite the fact that they are normally poorly soluble.Faster Drug Discovery? Friday, January 29, 2016 Startup develops more cost-effective test for assessing how cells respond to chemicals.Trillium Acquires Fluorinov Thursday, January 28, 2016 Trillium Therapeutics Inc. a clinical immuno-oncology company developing innovative therapies for the treatment of cancer, has announced that it has acquired all of the outstanding shares of Fluorinov Pharma Inc., a privately-held oncology company. ACD/Labs Celebrates 500th Customer in Asia & Pacific Region Thursday, January 28, 2016 ACD/Labs customers provide their unique perspectives on solutions deployed and used over the last decade.New Mechanism of Antitumor Action Identified Wednesday, January 27, 2016 A team of UAB researchers and collaborators from the Catalan biotech company Ability Pharmaceuticals (UAB Research Park), have described a new mechanism of anti-tumour action, identified during the study and development of the new drug ABTL0812.Nanoparticles Deliver Tumor Suppressors to Damaged Livers Wednesday, January 27, 2016 UT Southwestern Medical Center chemists have successfully used synthetic nanoparticles to deliver tumor-suppressing therapies to diseased livers with cancer, an important hurdle scientists have been struggling to conquer.Scientists Indicted For Allegedly Stealing GSK Trade Secrets Monday, January 25, 2016 An indictment was filed today charging five people in an alleged scheme to steal biopharmaceutical trade secrets from pharmaceutical company GlaxoSmithKline (GSK), announced United States Attorney Zane David Memeger. Experimental Combination Surprises with Anti-HIV Effectiveness Monday, January 25, 2016 A compound developed to protect the nervous system from HIV surprised researchers by augmenting the effectiveness of an investigational antiretroviral drug beyond anything expected.LDC, Roche Partner Monday, January 25, 2016 LDC and Roche will jointly advance innovative drug discovery projects.